2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Lymphopenia: new trials by email Literature Review of Lymphopenia trials Research Report on Lymphopenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Laboratory Biomarker Analysis, NT-I7, Placebo - Lymphopenia, Malignant Glioma | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 12 | 2018-10-30 | 2023-10-06 |
| Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE) CYT107 - Idiopathic CD4+ T-Lymphocytopenia | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 21 | 2009-02-01 | 2015-10-15 |
Glioma (1) · T-Lymphocytopenia, Idiopathic CD4-Positive (1)
Cytopenia (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Leukocyte Disorders (2) · Leukopenia (2) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1)
efineptakin alfa (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (2)
Jian L Campian, MD, PhD (1) · Virginia M Sheikh, M.D. (1)
UM1CA137443 (1)